LYZ and graft versus host disease: A range of HDPs, particularly lysozyme and/or lactoferrin, have been shown to be reduced in various types of DED, including SS and non-SS-related DED (176), evaporative DED (177), graft versus host disease (GvHD)-related DED (178), and others.